Clinically Relevant Outcomes Beyond Virologic Suppression

This AOI seeks evidence on the outcomes and value of CAB + RPV LA beyond maintaining virologic suppression. Focus may include adherence, persistence, patient-reported outcomes, impact on quality of life, stigma reduction, engagement in care, and the broader health impacts associated with increased touchpoints with healthcare providers afforded by CAB + RPV LA (i.e., treatment optimization of comorbid conditions and preventative healthcare interventions such as vaccinations, cancer screenings, and sexual health screenings).

ViiV ISR Area Of Interest Overview

Drug/Product Alignment

ViiV Products in Scope:	Cabotegravir
Treatment Type:	Long Acting-Treatment
Specify the Treatment Type:

Area of Interest/DataGap Description

Core Focus Area:	Quality of LIfe
Example Research Question(s):

Desirable Study Parameters

Populations of Interest:	All Patient Types
Geographical Regions:	Global

Version 20250909-disp

- Back to Top -

Clinically Relevant Outcomes Beyond Virologic Suppression

ViiV ISR Area Of Interest Overview

Pure Substance Request

Investigator Sponsored Study (ISS)

Collaborative Study